Dr. Kravchenko joined Chemical Diversity Research Institute (CDRI) in 1999, and was appointed CEO in 2003. Under his leadership, CDRI evolved into a biggest private Contract Research Organization in the Russian Federation. The company provides services in chemistry support, CMC, as well as in pre-clinical and clinical R&D programs from target identification to clinical candidate nomination and to Proof of Concept in the clinic. During the last 5 years, six drug candidates (CNS, Hepatitis and HIV) were advanced to clinical development.
Dr. Kravchenko is a seasoned professional, specializing in chemical technology of biologically-active compounds, especially drug discovery and development. D. Kravchenko obtained his Ditploma (M.S. equivalent) in 1995, and his Ph.D in 1998 from the Mendeleyev University of Chemical Technology of Russia (Moscow), his Dr. Chem. Sci. (Dr. Habil. equivalent) in 2006 at the International Friendship University of Russia (Moscow), and his MBA in 2009 from Higher Commercial Management School of the Russian Foreign Trade Academy, Ministry for Economic Development of Russia. Dr. Kravchenko has authored numerous publications and patents.